p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation

Cell Cycle

Volumn 11, Issue 18, 2012, Pages 3433-3442

  Wu, Chun Chi ^a   Yang, Tsung Ying ^b,d   Yu, Chang Tze Ricky ^c   Phan, Liem ^d   Ivan, Cristina ^d   Sood, Anil K ^d   Hsu, Shih Lan ^a,b   Lee, Mong Hong ^d,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHI NAN UNIVERSITY   (Taiwan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell cycle; Human non small cell lung carcinoma; Metronomic chemotherapy; mTOR; Oncogenes; Personalized cancer treatment; H2AX

Indexed keywords

AURORA A KINASE; CYCLIN DEPENDENT KINASE 2; PROTEIN FBW7 ALPHA; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CENTROSOME; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; ENZYME REGULATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

EID: 84866749750     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21732     Document Type: Article

References (41)

1. Toledo F, Wahl GM. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6:909-23; PMID:17128209; http://dx.doi.org/ 10.1038/nrc2012.
2. Soussi T, Béroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1:233-40; PMID:11902578; http://dx.doi.org/10.1038/35106009.
3. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005; 5:231-7; PMID:15738985; http://dx.doi.org/10.1038/nrc1560.
4. Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, et al. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 2001; 21:1297-310; PMID:11158315; http://dx.doi.org/10.1128/MCB.21.4.1297-1310.2001.
5. Lakin ND, Jackson SP. Regulation of p53 in response to DNA damage. Oncogene 1999; 18:7644-55; PMID:10618704; http://dx.doi.org/10.1038/sj.onc. 1203015.
6. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137:413-31; PMID:19410540; http://dx.doi.org/10.1016/j.cell. 2009.04.037.
7. Barlési F, Tchouhadjian C, Doddoli C, Villani P, Greillier L, Kleisbauer JP, et al. Gefitinib (ZD1839, Iressa) in non-small-cell lung cancer: a review of clinical trials from a daily practice perspective. Fundam Clin Pharmacol 2005; 19:385-93; PMID:15910663; http://dx.doi.org/10.1111/j.1472-8206. 2005.00323.x.
8. Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006; 13:951-61; PMID:16575405; http://dx.doi.org/10.1038/sj.cdd.4401916.
9. Giet R, Petretti C, Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol 2005; 15:241-50; PMID:15866028; http://dx.doi.org/10.1016/j.tcb.2005.03.004.
10. Agnese V, Bazan V, Fiorentino FP, Fanale D, Badalamenti G, Colucci G, et al. The role of Aurora-A inhibitors in cancer therapy. Ann Oncol 2007; 18(Suppl 6):vi47-52; PMID:17591831; http://dx.doi.org/10.1093/annonc/mdm224.
11. He L, Yang H, Ma Y, Pledger WJ, Cress WD, Cheng JQ. Identification of Aurora-A as a direct target of E2F3 during G2/M cell cycle progression. J Biol Chem 2008; 283:31012-20; PMID:18776222; http://dx.doi.org/10.1074/jbc. M803547200.
12. Tanaka M, Ueda A, Kanamori H, Ideguchi H, Yang J, Kitajima S, et al. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem 2002; 277:10719-26; PMID:11790771; http://dx.doi.org/10.1074/jbc.M108252200.
13. Udayakumar TS, Belakavadi M, Choi KH, Pandey PK, Fondell JD. Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1. J Biol Chem 2006; 281:14691-9; PMID:16574658; http://dx.doi.org/10.1074/jbc.M600163200.
14. Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004; 432:775-9; PMID:15592418; http://dx.doi.org/10.1038/nature03155.
15. Kufer TA, Silljé HH, Körner R, Gruss OJ, Meraldi P, Nigg EA. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002; 158:617-23; PMID:12177045; http://dx.doi.org/10.1083/jcb.200204155.
16. Eyers PA, Erikson E, Chen LG, Maller JL. A novel mechanism for activation of the protein kinase Aurora A. Curr Biol 2003; 13:691-7; PMID:12699628; http://dx.doi.org/10.1016/S0960-9822(03)00166-0.
17. Lim SK, Gopalan G. Aurora-A kinase interacting protein 1 (AURKAIP1) promotes Aurora-A degradation through an alternative ubiquitin-independent pathway. Biochem J 2007; 403:119-27; PMID:17125467; http://dx.doi.org/10.1042/ BJ20061272.
18. Portier N, Audhya A, Maddox PS, Green RA, Dammermann A, Desai A, et al. A microtubuleindependent role for centrosomes and aurora a in nuclear envelope breakdown. Dev Cell 2007; 12:515-29; PMID:17419991; http://dx.doi.org/10.1016/j. devcel.2007.01.019.
19. Yu X, Minter-Dykhouse K, Malureanu L, Zhao WM, Zhang D, Merkle CJ, et al. Chfr is required for tumor suppression and Aurora A regulation. Nat Genet 2005; 37:401-6; PMID:15793587; http://dx.doi.org/10.1038/ng1538.
20. Fujii Y, Yada M, Nishiyama M, Kamura T, Takahashi H, Tsunematsu R, et al. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Cancer Sci 2006; 97:729-36; PMID:16863506; http://dx.doi.org/10.1111/j.1349-7006.2006.00239.x.
21. Gottifredi V, Karni-Schmidt O, Shieh SS, Prives C. p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol Cell Biol 2001; 21:1066-76; PMID:11158294; http://dx.doi.org/10.1128/MCB.21.4.1066-1076.2001.
22. Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LLY, Cheng AL. Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death. Oncogene 2004; 23:3580-8; PMID:15116093; http://dx.doi.org/10.1038/ sj.onc.1207426.
23. Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ 2008; 15:530-44; PMID:18064040; http://dx.doi.org/10.1038/sj.cdd.4402287.
24. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998; 12:2245-62; PMID:9694791; http://dx.doi.org/10.1101/gad.12.15.2245.
25. Cooper CS, Nicholson AG, Foster C, Dodson A, Edwards S, Fletcher A, et al. Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer 2006; 54:155-62; PMID:16938365; http://dx.doi.org/10.1016/j. lungcan.2006.07.005.
26. Adams RR, Carmena M, Earnshaw WC. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 2001; 11:49-54; PMID:11166196; http://dx.doi.org/10.1016/S0962-8924(00)01880-8.
27. Carmena M, Ruchaud S, Earnshaw WC. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr Opin Cell Biol 2009; 21:796-805; PMID:19836940; http://dx.doi.org/10.1016/j.ceb.2009.09.008.
28. Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, et al. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem 2004; 279:50110-9; PMID:15364936; http://dx.doi.org/10. 1074/jbc.M409226200.
29. Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002; 21:483-92; PMID:11847097; http://dx.doi.org/10.1093/emboj/21.4.483.
30. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004; 36:55-62; PMID:14702041; http://dx.doi.org/ 10.1038/ng1279.
31. Vader G, Lens SM. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 2008; 1786:60-72; PMID:18662747.
32. Feng Z, Hu W, Rajagopal G, Levine AJ. The tumor suppressor p53: cancer and aging. Cell Cycle 2008; 7:842-7; PMID:18414039; http://dx.doi.org/10.4161/ cc.7.7.5657.
33. Wang W, El-Deiry WS. Restoration of p53 to limit tumor growth. Curr Opin Oncol 2008; 20:90-6; PMID:18043262; http://dx.doi.org/10.1097/CCO. 0b013e3282f31d6f.
34. Gully CP, Velazquez-Torres G, Shin JH, Fuentes-Mattei E, Wang E, Carlock C, et al. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci USA 2012; 109:E1513-22; PMID:22611192; http://dx.doi.org/10.1073/ pnas.1110287109.
35. Huang H, Huang SY, Chen TT, Chen JC, Chiou CL, Huang TM. Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells. J Cell Biochem 2004; 91:756-65; PMID:14991767; http://dx.doi.org/10. 1002/jcb.10769.
36. Sedletska Y, Giraud-Panis MJ, Malinge JM. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticancer Agents 2005; 5:251-65; PMID:15992353; http://dx.doi.org/10.2174/1568011053765967.
37. Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 2002; 303:124-31; PMID:12235242; http://dx.doi.org/10.1124/jpet.102.037192.
38. Mao JH, Wu D, Perez-Losada J, Jiang T, Li Q, Neve RM, et al. Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice. Cancer Cell 2007; 11:161-73; PMID:17292827; http://dx.doi.org/10.1016/j.ccr.2006.11.025.
39. Nair JS, Ho AL, Tse AN, Coward J, Cheema H, Ambrosini G, et al. Aurora B kinase regulates the post-mitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780. Mol Biol Cell 2009; 20:2218-28; PMID:19225156; http://dx.doi.org/10.1091/mbc.E08-08-0885.
40. Crane R, Gadea B, Littlepage L, Wu H, Ruderman JV. Aurora A, meiosis and mitosis. Biol Cell 2004; 96:215-29; PMID:15182704; http://dx.doi.org/10.1016/j. biolcel.2003.09.008.
41. Cheng CC, Hsueh CM, Liang KW, Ting CT, Wen CL, Hsu SL. Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells. Eur J Pharmacol 2011; 650:519-25; PMID:21044622; http://dx.doi.org/10.1016/j.ejphar.2010.10.051.